PHS
TCOM icon

PFM Health Sciences’s Trip.com Group TCOM Stock Holding History

PFM Health Sciences’s Portfolio TCOM Stock Details TCOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-927,160
Closed -$34.2M – 101
2019
Q2 		$34.2M Buy
927,160
+547,650
+144% +$21.6M 0.65% 51
2019
Q1 		$16.6M Buy
+379,510
New +$13.3M 0.37% 68
2018
Q3 		– Sell
-826,224
Closed -$39.4M – 132
2018
Q2 		$39.4M Buy
+826,224
New +$37.3M 0.62% 66
2016
Q2 		– Sell
-487,352
Closed -$21.6M – 102
2016
Q1 		$21.6M Buy
+487,352
New +$20.4M 0.67% 47
2014
Q4 		– Sell
-1,874,654
Closed -$53.2M – 98
2014
Q3 		$53.2M Sell
1,874,654
-403,790
-18% -$12.8M 1.22% 29
2014
Q2 		$73M Buy
2,278,444
+434,026
+24% +$11.7M 1.46% 26
2014
Q1 		$46.5M Buy
+1,844,418
New +$42.3M 0.84% 38

Other funds holding TCOM

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PFM Health Sciences's TCOM Position: Q3 2019 in Review

PFM Health Sciences sold out of Trip.com Group (TCOM) in Q3 2019, closing a stake of 927,160 shares — an estimated $34.2M sold.

PFM Health Sciences first reported a position in TCOM in Q1 2014 and held it in 7 quarters. The position peaked at $73M in Q2 2014. 359 funds tracked by Wall St. Rank hold TCOM as of Q3 2019.

  • PFM Health Sciences reported no remaining Trip.com Group position as of Q3 2019 after selling out during the quarter.
  • PFM Health Sciences sold 927,160 Trip.com Group shares in Q3 2019, an estimated $34.2M.
  • PFM Health Sciences first reported a position in Trip.com Group in Q1 2014 and held it in 7 quarters.
  • PFM Health Sciences's Trip.com Group position peaked at $73M in Q2 2014.
  • 359 funds tracked by Wall St. Rank held Trip.com Group as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.